112 related articles for article (PubMed ID: 21122402)
1. [Treatment of severe aplastic anemia with intensified immunosuppressive therapy and two different regimens with recombinant human granulocyte colony-stimulating factor: a retrospective study based on long-term follow-up].
Li YM; Li XX; Ge ML; Shi J; Qian LS; Wang JX; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):470-4. PubMed ID: 21122402
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
3. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
[TBL] [Abstract][Full Text] [Related]
4. Trilineage response in severe aplastic anemia following long-term therapy with recombinant human granulocyte colony-stimulating factor.
Ashihara E; Shimazaki C; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Nakagawa M
Acta Haematol; 1993; 90(3):159-61. PubMed ID: 7507289
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
Ohara A; Kojima S; Hamajima N; Tsuchida M; Imashuku S; Ohta S; Sasaki H; Okamura J; Sugita K; Kigasawa H; Kiriyama Y; Akatsuka J; Tsukimoto I
Blood; 1997 Aug; 90(3):1009-13. PubMed ID: 9242530
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)].
Kojima S; Matsuyama T; Miyazaki T; Sakurada K; Shike S; Okino E; Akabane T; Nakahata T; Okuni M; Mugishima H
Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006
[TBL] [Abstract][Full Text] [Related]
8. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
[TBL] [Abstract][Full Text] [Related]
11. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
[TBL] [Abstract][Full Text] [Related]
12. [Effect and safety of pegylated recombinant human G-CSF on hematopoietic reconstitution after autologous hematopoietic stem cell transplantation in lymphoma patients].
Shen YG; Ji MM; Zheng Z; Tang W; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2022 Nov; 43(11):940-945. PubMed ID: 36709186
[No Abstract] [Full Text] [Related]
13. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
14. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human granulocyte-colony stimulation factor (rhG-CSF) on immune system in pediatric patients with aplastic anemia.
Hibi S; Yoshihara T; Nakajima F; Misu H; Mabuchi O; Imashuku S
Pediatr Hematol Oncol; 1994; 11(3):319-23. PubMed ID: 7520260
[TBL] [Abstract][Full Text] [Related]
16. [A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].
Liu KQ; Wang Y; Zhao Z; Lin D; Zhou CL; Liu BC; Gong XY; Zhao XL; Wei SN; Zhang GJ; Gong BF; Li Y; Liu YT; Mi YC; Wang JX; Wei H
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):497-501. PubMed ID: 31340623
[No Abstract] [Full Text] [Related]
17. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].
Asano S; Hirashima K; Yoshida Y; Takaku F; Miyazaki T; Omine M; Furusawa S; Abe T; Mori M; Arimori S
Rinsho Ketsueki; 1990 Sep; 31(9):1456-62. PubMed ID: 1701008
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
[TBL] [Abstract][Full Text] [Related]
20. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]